Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 7.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Allergan plc & Ironwood Pharmaceuticals, Inc.

1st Annual Live Medical Crossfire®: IBS and IBD

Release Date: July 30, 2020
Expiration Date: July 30, 2021

Activity Overview

This online, on-demand virtual symposium brings together faculty who are renowned clinician-researchers in the management of either irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD) for in-depth exploration of key aspects of care. In individual presentations, faculty review recent and emerging trial data and provide commentary on their clinical impact. Using panel discussions, patient cases are presented with clinical trial data tightly integrated to illuminate frontline, later-line, and maintenance therapy strategies. Adverse event recognition and management is educationally tied to case presentations. Future directions in the field will also be addressed and considered regarding how recent developments and highly anticipated trials may shape care.

This educational activity is an archive of a live virtual symposium held on June 27, 2020.

Acknowledgement of Support

This activity is supported by an educational grant from Allergan plc & Ironwood Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is primarily directed toward gastroenterologists and primary care physicians. Nurse practitioners, physician assistants, pharmacists, researchers, and other health care professionals involved in the treatment and management of IBS and IBD will also be invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify key clinical features, diagnostic work-up, and referral strategies in determining a diagnosis of IBS/CIC and IBD
  • Review current guideline recommendations for patient-centered/individualized care in the management of IBS/CIC and IBD
  • Evaluate efficacy and safety data for new and emerging treatments for IBS/CIC and IBD
  • Develop collaborative multidisciplinary management strategies for long-term management IBS/CIC and IBD
  • Employ communication tools to build and improve patient-physician relationships aimed at enhancing patient participation in their care

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

William D. Chey, MD
William D. Chey, MD
Professor of Gastroenterology & Nutrition Sciences
Director, GI Physiology Laboratory
Director, Digestive Disorders Nutrition & Lifestyle Program
Codirector, Michigan Bowel Control Program
Michigan Medicine Gastroenterology Clinic
Ann Arbor, MI

Disclosures: Grant Research Support: Biomerica Inc, Commonwealth Diagnostics International Inc, QOL Medical LLC, Urovant Sciences Ltd, Vibrant Pharma Inc; Consultant: Biomerica Inc, Ironwood Pharmaceuticals Inc, QOL Medical LLC, Salix Pharmaceuticals/Valeant, Ritter Pharmaceuticals, Takeda Pharmaceutical Co Ltd, Urovant Sciences Ltd, Vibrant Pharma Inc; Shareholder: ModifyHealth LLC, Ritter Pharmaceuticals.

Bruce Sands, MD, MS
Bruce Sands, MD, MS
Dr. Burrill B. Crohn Professor of Medicine
Icahn School of Medicine at Mount Sinai
Chief, Dr. Henry D. Janowitz Division of Gastroenterology
Mount Sinai Health System
New York, NY

Disclosures: Grant Research Support: Theravance Biopharma Inc; Consultant: AbbVie Inc, Arena Pharmaceuticals Inc, AstraZeneca plc, Boehringer Ingelheim Pharmaceuticals Inc, Boston Pharmaceuticals Inc, Celltrion Healthcare Co Ltd, Genentech Inc, F. Hoffmann-La Roche Ltd, Immunic Inc, Ironwood Pharmaceuticals Inc, Janssen Pharmaceuticals Inc, Eli Lilly and Company, Morphic Therapeutic, Oppilan Pharma Inc, OSE Immunotherapeutics SA, Otsuka Pharmaceutical Co Ltd, Pfizer Inc, Prometheus Laboratories Inc, RedHill Biopharma Ltd, Shire, Takeda Pharmaceutical Co Ltd, TARGET PharmaSolutions Inc, Theravance Biopharma Inc.

Anita Afzali, MD, MPH
Anita Afzali, MD, MPH
Medical Director
Inflammatory Bowel Disease Center
The Ohio State University Wexner Medical Center
Columbus, OH

Disclosures: Grant Research Support: AbbVie Inc, Bristol Myers Squibb Company, Janssen Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd; Consultant: AbbVie Inc, Celgene Corporation, Janssen Pharmaceuticals Inc, Pfizer Inc, Takeda Pharmaceutical Co Ltd; Speakers Bureau: AbbVie Inc, Celgene Corporation, Janssen Pharmaceuticals Inc, Pfizer Inc, Takeda Pharmaceutical Co Ltd; Other: IBD Horizons.

Nitin Ahuja, MD, MS
Nitin Ahuja, MD, MS
Assistant Professor of Clinical Medicine
University of Pennsylvania
Philadelphia, PA

Disclosures: Grant Research Support: Allergan plc, Medtronic PLC, Vanda Pharmaceuticals Inc.

Jessica R. Allegretti, MD, MPH
Jessica R. Allegretti, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Associate Director
Crohn’s and Colitis Center
Brigham and Women’s Hospital
Boston, MA

Disclosures: Grant Research Support: Merck & Co Inc; Consultant: Artugen Therapeutics, Finch Therapeutics, Iterative Scopes Inc, Janssen Pharmaceuticals Inc, Pandion Therapeutics, Pfizer Inc, Servatus Ltd, Takeda Pharmaceutical Co Ltd.

Brooks D. Cash, MD, AGAF, FACG, FASGE
Brooks D. Cash, MD, AGAF, FACG, FASGE
Chief, Division of Gastroenterology, Hepatology, and Nutrition
Dan and Lillie Sterling Professor of Medicine
The University of Texas Health Science Center at Houston
Endowed Director, Ertan Digestive Disease Center
Memorial Hermann-Texas Medical Center
Houston, TX

Disclosures: Grant Research Support: Napo Pharmaceuticals Inc; Consultant: Allergan plc, Salix Pharmaceuticals, Takeda Pharmaceutical Co Ltd; Speakers Bureau: Allergan plc, QOL Medical LLC, Salix Pharmaceuticals, Takeda Pharmaceutical Co Ltd.

Ari Grinspan, MD
Ari Grinspan, MD
Assistant Professor of Medicine and Gastroenterology
The Dr. Henry D. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Ari Grinspan, MD, has no relevant financial relationships with commercial interests to disclose.

Maia Kayal, MD
Maia Kayal, MD
Assistant Professor of Medicine and Gastroenterology
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Maria Kayal, MD, has no relevant financial relationships with commercial interests to disclose.

Brian E. Lacy, MD, PhD
Brian E. Lacy, MD, PhD
Professor of Medicine
Senior Associate Consultant
Mayo Clinic
Jacksonville, FL

Disclosures: Grant Research Support: Bausch Health – diabetic gastroparesis; Consultant: Allergan plc, Arena Pharmaceuticals Inc, Ironwood Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd.

Anthony Lembo, MD
Anthony Lembo, MD
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures: Consultant: Ardelyx Inc, Arena Pharmaceuticals Inc, Ironwood Pharmaceuticals Inc, Mylan NV, Salix Pharmaceuticals, Takeda Pharmaceutical Co Ltd.

Gary R. Lichtenstein, MD
Gary R. Lichtenstein, MD
Professor of Medicine
Perelman School of Medicine
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
The Ruth and Raymond Perelman Center for Advanced Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA

Disclosures: Grant Research Support: Janssen Orthobiotech, UCB SA; Consultant: AbbVie Inc, American Regent Inc, CellCeutix Corporation, Celgene Corporation, Endo Pharmaceuticals Inc, Ferring Pharmaceuticals, Gilead Sciences Inc, Janssen Orthobiotech, Eli Lilly and Company, American Regent Inc, Merck & Co Inc, Morphic Therapeutic, Pfizer Inc, Prometheus Laboratories Inc, Romark Pharmaceuticals, Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, Takeda Pharmaceutical Co Ltd, UCB SA; Other: Gastroenterology and Hepatology (Gastro-Hep Communications Inc), Editor Honorarium; Professional Communications Inc, Book Royalty; SLACK Inc, Book Royalty; Up-To-Date Inc, Author Honorarium.

Konstantinos Papamichail, MD, PhD
Konstantinos Papamichail, MD, PhD
Research Fellow in Medicine
Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Boston, MA

Disclosures: Other: I have received a lecture fee from Mitsubishi Tanabe Pharma America.

Mark Pimentel, MD
Mark Pimentel, MD
Executive Director, Medically Associated Science and Technology (MAST) Program
Associate Professor of Medicine and Gastroenterology
Cedars-Sinai Medical Center
Los Angeles, CA

Disclosures: Grant Research Support: Bausch Health; Consultant: 9 meters Biopharma Inc, Bausch Health, Gemelli Biotech Corp, Lupin Pharmaceuticals Inc, Progenity Inc, Synthetic Biologics Inc; Shareholder: Gemelli Biotech Corp, Synthetic Biologics Inc; Other: Cedars licensing agreement – 9 meters Biopharma Inc, Aytu Bioscience Inc, Bausch Health, Gemelli Biotech Corp, Synthetic Biologics Inc.

Eamonn M. Quigley, MD, FRCP, FACP, MACG, FRCPI, MWGO
Eamonn M. Quigley, MD, FRCP, FACP, MACG, FRCPI, MWGO
David M. Underwood Chair of Medicine in Digestive Disorders
Director, Lynda K. and David M. Underwood Center for Digestive Disorders
Chief, Gastroenterology and Hepatology
Professor of Medicine
Institute of Academic Medicine
Houston Methodist Hospital
Professor of Medicine
Weill Cornell Medical College
Adjunct Professor of Medicine
Texas A&M Health Science Center College of Medicine
Adjunct Professor, School of Medicine,
University College Cork, Ireland
Houston, TX

Disclosures: Grant Research Support: 4D Pharma plc, Biomerica Inc, Takeda Pharmaceutical Co Ltd, Vibrant Pharma Inc, Zealand Pharma A/S; Consultant: 4D Pharma plc, Alimentary Health, Allergan plc, Biocodex Inc, Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals, Vibrant Pharma; Shareholder: Alimentary Health.

Eric D. Shah, MD, MBA
Eric D. Shah, MD, MBA
Assistant Professor of Medicine
Audrey and Theodor Geisel School of Medicine at Dartmouth
Director, Gastrointestinal Motility, Esophageal and Swallowing Disorders Center
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Disclosures: Grant Research Support: AGA Research Foundation's 2019 AGA-Shire Research Scholar Award in Functional GI and Motility Disorders.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
25262728293031
Filter By